We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+5.13%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$775M
AUM Growth
-$436M
Cap. Flow
-$471M
Cap. Flow %
-60.72%
Top 10 Hldgs %
18.21%
Holding
4,545
New
711
Increased
1,179
Reduced
1,568
Closed
1,030

Sector Composition

Rank Sector Weight
1 Financials 11.08%
2 Technology 10%
3 Consumer Discretionary 7.02%
4 Healthcare 6.86%
5 Communication Services 6.81%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNP
2301
DELISTED
Juniper Pharmaceuticals, Inc. Common Stock
JNP
$15K ﹤0.01%
3,125
+151
+5% +$734
NSM
2302
DELISTED
Nationstar Mortgage Holdings
NSM
$15K ﹤0.01%
834
-921
-52% -$16.8K
GNCMA
2303
DELISTED
GCI Liberty, Inc. Class A-1 Common Stock
GNCMA
$15K ﹤0.01%
387
+23
+6% +$938
TTF
2304
DELISTED
Thai Fund
TTF
$15K ﹤0.01%
+1,394
New +$15.1K
ALCO icon
2305
Alico
ALCO
$283M
$14K ﹤0.01%
473
+53
+13% +$1.71K
ALK icon
2306
Alaska Air
ALK
$5.58B
$14K ﹤0.01%
193
+139
+257% +$9.88K
AMN icon
2307
AMN Healthcare
AMN
$1.4B
$14K ﹤0.01%
276
-1,519
-85% -$69.2K
CVSA
2308
Covista Inc
CVSA
$4.8B
$14K ﹤0.01%
325
-2,048
-86% -$80.3K
BTE icon
2309
Baytex Energy
BTE
$2.92B
$14K ﹤0.01%
3,763
-25,280
-87% -$74.5K
CINF icon
2310
Cincinnati Financial
CINF
$27.1B
$14K ﹤0.01%
186
-295
-61% -$22K
EBF icon
2311
Ennis
EBF
$564M
$14K ﹤0.01%
658
-4,490
-87% -$89.9K
EPC icon
2312
Edgewell Personal Care
EPC
$1.31B
$14K ﹤0.01%
+229
New +$14.4K
EVC icon
2313
Entravision Communication
EVC
$1.1B
$14K ﹤0.01%
1,991
-7,046
-78% -$44.2K
FENC icon
2314
Fennec Pharmaceuticals
FENC
$402M
$14K ﹤0.01%
1,091
+691
+173% +$6.89K
FOLD
2315
DELISTED
Amicus Therapeutics
FOLD
$14K ﹤0.01%
944
-4,934
-84% -$67.8K
FORR icon
2316
Forrester Research
FORR
$228M
$14K ﹤0.01%
326
-265
-45% -$11.9K
COLO
2317
Global X MSCI Colombia ETF
COLO
$207M
$14K ﹤0.01%
353
-1,322
-79% -$52.5K
HIMX
2318
Himax Technologies
HIMX
$2.55B
$14K ﹤0.01%
1,365
+898
+192% +$9.74K
HLIO icon
2319
Helios Technologies
HLIO
$2.76B
$14K ﹤0.01%
215
-2,375
-92% -$139K
HQH
2320
abrdn Healthcare Investors
HQH
$1.32B
$14K ﹤0.01%
600
-331
-36% -$7.75K
INBK icon
2321
First Internet Bancorp
INBK
$255M
$14K ﹤0.01%
368
-2,029
-85% -$75.8K
KRC icon
2322
Kilroy Realty
KRC
$4.42B
$14K ﹤0.01%
+194
New +$14.3K
MCS icon
2323
Marcus Corp
MCS
$945M
$14K ﹤0.01%
499
-6,291
-93% -$173K
MNOV icon
2324
MediciNova
MNOV
$66M
$14K ﹤0.01%
2,090
-1,574
-43% -$10.4K
MOFG
2325
DELISTED
MidWestOne Financial Group
MOFG
$14K ﹤0.01%
409
-1,240
-75% -$43.8K

Similar funds

Tower Research Capital (TRC)'s Q4 2017 Portfolio in Review

As of Q4 2017, Tower Research Capital (TRC) held 4,545 positions worth $775M, down 36% from $1.21B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Tower Research Capital (TRC) withdrew a net $471M in Q4 2017, closing 1,030 positions and reducing 1,568 holdings. Its most notable exit was iShares MSCI EAFE ETF, an estimated $25.9M position sold in full.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 6.3% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Tower Research Capital (TRC) opened a new position in Berkshire Hathaway Class B worth $7.94M.

  • Tower Research Capital (TRC)'s largest Q4 2017 buy was Berkshire Hathaway Class B: 40,072 shares worth $7.94M.
  • Tower Research Capital (TRC) added most to Apple in Q4 2017, an estimated $8.74M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $223M.
  • Tower Research Capital (TRC) fully exited iShares MSCI EAFE ETF in Q4 2017, selling an estimated $25.9M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 18% of its $775M portfolio in Q4 2017.
  • Tower Research Capital (TRC) opened 711 new positions and closed 1,030 in Q4 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 36% quarter-over-quarter to $775M.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.